Invicta Diagnostic Limited (NSE:INVICTA)

Market Cap	822.84M
Revenue (ttm)	301.81M +89.8%
Net Income	48.92M
EPS	5.81
Shares Out	12.57M
PE Ratio	11.26
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	72,000
Average Volume	35,120
Open	74.25
Previous Close	70.85
Day's Range	65.35 - 75.40
52-Week Range	58.10 - 105.00
Beta	n/a
RSI	47.89
Earnings Date	Mar 2, 2026

About Invicta Diagnostic

Invicta Diagnostic Limited owns and operates diagnostic centers under the PC Diagnostics brand name in India. It provides pathology and radiology testing services, such as imaging, pathology/clinical laboratory, and tele-radiology; cytogenetics and high-end molecular diagnostic tests; X-rays and ultrasounds; and computerized tomography (CT), magnetic resonance imaging, and positron emission tomography CT scans. The company also offers value-added services, including home collection of specimens and house calls, and various delivery or access mo...

• Industry: Medical Laboratories
• Founded: 2016
• Employees: 113
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INVICTA

Financial Performance

In fiscal year 2025, Invicta Diagnostic's revenue was 301.81 million, an increase of 89.84% compared to the previous year's 158.98 million. Earnings were 48.92 million, an increase of 30.04%.